Welcome to Demei Chemical Technology Co., Ltd
📞 +86-0536-2205782 📧 info@demeichem.com
Language: English | Japanese | Russian

K 251T

CAS No.: 548-77-6

  • Molecular Formula: C₁₆H₁₂O₆
  • Molecular Weight: 300.26 g/mol

Chemical type

  • Isoflavone (flavonoid aglycone)
[1]
  • Isoflavone compound
  • Flavonoid glycoside
[2]

Key properties

  • Produced via hydrolysis of tectoridin; contains O group on benzene rings; part of flavonoid family with potential antioxidant and defensive properties.
[1]
  • Anti-inflammatory
  • Antibacterial
  • Anti-tumor
  • Anti-oxidant
  • Inhibits M1-like macrophage polarization
[2]
  • Plant defense and growth regulation; product of β-glucosidase activity in enzymatic assays.
[1]
  • Therapeutic agent for Sepsis-associated acute kidney injury (SA-AKI)
  • Reduces inflammation in renal tubular epithelial cells
[2]

Classification by use

  • Chemicals involved in plant defense
[1]
  • Pharmaceutical / Therapeutic agent
  • Natural product-derived compound
[2]

A trustworthy factory and manufacturer

Demei Chemical Technology Co., Ltd. is a modern high-tech enterprise integrating R&D, production, and sales. The company's founder, Dr. Arron, born in April 1975, graduated from the School of Mechanical Engineering at Yanshan University and has been engaged in research in the fields of mechanical engineering and chemical synthesis for many years. The company's products focus on the chemical industry, primarily dealing in chemical raw materials and chemical production machinery and equipment. With its strong technical capabilities, advanced production equipment, and strict quality management system, the company has earned the trust of customers worldwide.

  1. [Cite:1] A novel beta-glucosidase gene from Angelica dahurica and insights into the metabolic pathway of scopoletin, Industrial Crops and Products, Volume 231, 1 September 2025, 121219
  2. [Cite:2] Tectorigenin could alleviate SA-AKI via reducing M1-like polarization of macrophages through KLF4/NF-κB pathway, International Immunopharmacology, Volume 164, 30 October 2025, 115300